• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Emphysema Market

    ID: MRFR/Pharma/4354-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    Emphysema Market Research Report By Type (Centrilobular, Panlobular), By Diagnosis (Imaging Test (X-Ray, Ct Scan), Lung Function Test), by Treatment (Medication (Antibiotics, Bronchodilators), Therapy, Surgery), by End-User-Global Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Emphysema Market Infographic
    Purchase Options

    Emphysema Market Summary

    The Global Emphysema Market is projected to grow from 13.5 USD Billion in 2024 to 22.7 USD Billion by 2035, indicating robust expansion.

    Key Market Trends & Highlights

    Global Emphysema Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate of 4.83 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 22.7 USD Billion, reflecting a substantial increase from 13.5 USD Billion in 2024.
    • The growth trajectory suggests a rising demand for innovative treatment options in the emphysema sector.
    • Growing adoption of advanced therapies due to increasing prevalence of respiratory diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 13.5 (USD Billion)
    2035 Market Size 22.7 (USD Billion)
    CAGR (2025-2035) 4.83%

    Major Players

    Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc.

    Emphysema Market Drivers

    Growing Geriatric Population

    The aging population is a critical driver of the Global Global Emphysema Market Industry. As individuals age, the risk of developing respiratory diseases, including emphysema, increases significantly. The World Health Organization reports that the global population aged 60 years and older is expected to double by 2050, leading to a higher incidence of chronic respiratory conditions. This demographic shift necessitates enhanced healthcare services and treatment options tailored to older adults. Consequently, the Global Global Emphysema Market Industry is likely to see sustained growth, with a compound annual growth rate of 4.83% projected from 2025 to 2035, as the demand for effective management of emphysema rises.

    Advancements in Treatment Options

    Innovations in treatment methodologies are propelling the Global Global Emphysema Market Industry forward. New pharmacological therapies, including bronchodilators and corticosteroids, are being developed to enhance patient outcomes. Additionally, the emergence of biologics and targeted therapies offers promising avenues for managing emphysema. Clinical trials and research initiatives are ongoing, suggesting that these advancements could lead to improved efficacy and safety profiles for patients. As the industry evolves, the market is projected to grow, potentially reaching 22.7 USD Billion by 2035, reflecting the increasing investment in research and development within the Global Global Emphysema Market Industry.

    Increased Awareness and Education

    Rising awareness and education regarding respiratory health are influencing the Global Global Emphysema Market Industry positively. Public health campaigns and initiatives aimed at educating individuals about the risks associated with smoking and air pollution are gaining traction. These efforts are likely to lead to earlier diagnosis and treatment of emphysema, ultimately improving patient outcomes. Furthermore, healthcare providers are increasingly focusing on preventive measures, which may reduce the overall burden of the disease. As awareness continues to grow, the market is expected to expand, aligning with the projected increase in market value to 22.7 USD Billion by 2035.

    Market Trends and Growth Projections

    The Global Global Emphysema Market Industry is characterized by various trends that indicate its growth trajectory. The market is projected to expand significantly, with estimates suggesting a value of 22.7 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 4.83% from 2025 to 2035. Key trends include the increasing adoption of telemedicine for respiratory care, the integration of artificial intelligence in diagnostics, and the rise of personalized medicine approaches. These trends reflect the industry's adaptability and responsiveness to changing healthcare needs, positioning the Global Global Emphysema Market Industry for a robust future.

    Regulatory Support and Policy Initiatives

    Supportive regulatory frameworks and policy initiatives are fostering growth in the Global Global Emphysema Market Industry. Governments worldwide are implementing policies aimed at reducing tobacco use and improving air quality, which are crucial in combating respiratory diseases. Initiatives such as smoking cessation programs and stricter emissions regulations are likely to contribute to a decrease in new emphysema cases. This regulatory environment not only encourages innovation in treatment but also promotes public health. As a result, the Global Global Emphysema Market Industry is positioned for growth, with expectations of reaching 13.5 USD Billion in 2024.

    Rising Prevalence of Respiratory Diseases

    The Global Global Emphysema Market Industry is experiencing growth due to the increasing prevalence of respiratory diseases. Factors such as air pollution, smoking, and occupational hazards contribute significantly to the rise in emphysema cases. According to health statistics, millions of individuals are diagnosed with chronic obstructive pulmonary disease (COPD), which includes emphysema, highlighting the urgent need for effective treatment options. This growing patient population is expected to drive market demand, with projections indicating that the market could reach 13.5 USD Billion in 2024. As awareness of respiratory health continues to rise, the Global Global Emphysema Market Industry is likely to expand further.

    Market Segment Insights

    Emphysema Type Insights

    On the basis of type, the market is segmented into centrilobular and panlobular emphysema.

    Emphysema Diagnosis Insights

    On the basis of diagnosis, the market is segmented into imaging test, lung function test, and others. The imaging test is further segmented into chest X-ray and CT scan.

    Emphysema Treatment Insights

    On the basis of treatment, the market is segmented into medications, therapy, and surgery. Medications are further segmented into smoking cessation drugs, bronchodilators, inhaled steroids, antibiotics, and leukotriene modifiers. Therapy is further segmented into pulmonary rehabilitation, nutrition therapy, gene therapy, and supplemental oxygen. Surgery is further segmented into lung volume reduction surgery, lung transplant, and bullectomy.

    Emphysema End-User Insights

    On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.

    Get more detailed insights about Emphysema Market Research Report - Forecast to 2032

    Key Companies in the Emphysema Market market include

    Future Outlook

    Emphysema Market Future Outlook

    The Global Emphysema Market is projected to grow at a 4.83% CAGR from 2024 to 2035, driven by advancements in treatment options, increasing prevalence, and heightened awareness.

    New opportunities lie in:

    • Develop innovative drug delivery systems to enhance treatment efficacy.
    • Expand telehealth services for remote patient monitoring and management.
    • Invest in personalized medicine approaches to tailor therapies for individual patients.

    By 2035, the Global Emphysema Market is expected to demonstrate robust growth, reflecting evolving treatment paradigms and increased patient engagement.

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 12.23 (USD Billion)
    Market Size 2024 13.53 (USD Billion)
    Market Size 2032 19.83 (USD Billion)
    Compound Annual Growth Rate (CAGR) 4.64 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc. and others.
      Key Market Opportunities Increasing population in urban areas across the globe and growing number of tobacco smokers.
      Key Market Drivers The growing prevalence of respiratory diseases is the major driver for the Emphysema Market.

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is Emphysema?

    Emphysema is a lung disease characterized by shortness of breath, causing damage to the air sacs in the lungs.

    What is the CAGR of the Emphysema Market?

    Global Emphysema Market is expected to exhibit a strong 4.64% CAGR over the forecast period from 2024 to 2032.

    What is the major driver for the Emphysema Market?

    The growing prevalence of respiratory diseases is the major driver for the Emphysema Market.

    Which is the major regional Emphysema Market?

    The Americas dominate the Global Emphysema Market.

    What are the key players in the Emphysema Market?

    Leading players in the Emphysema Market include Pulmonx Inc., Intrexon Corporation, and Halozyme Therapeutics, among others.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials